|
2024-10-01 |
2024-09-30 |
K
Kauf
|
Hitchcock Michael J.M.
Nicht geschäftsführender Verwaltungsratsmitglied
|
10.000
+200.0%
10,06
100.600 USD
|
10.000
+200.0%
|
10,06
|
100.600 USD
|
|
|
2024-06-12 |
2024-06-11 |
K
Kauf
|
Valle Franco
Chief Financial Officer
Führungsperson
|
12.509
+41.7%
4,43
55.361 USD
|
12.509
+41.7%
|
4,43
|
55.361 USD
|
|
|
2023-06-02 |
2023-06-01 |
V
Verkauf
|
A2A Pharmaceuticals, Inc.
Large shareholder
|
50.000
-1.4%
34,56
1.728.165 USD
|
50.000
-1.4%
|
34,56
|
1.728.165 USD
|
|
|
2023-06-02 |
2023-05-31 |
V
Verkauf
|
A2A Pharmaceuticals, Inc.
Large shareholder
|
75.000
-2.1%
33,81
2.535.750 USD
|
75.000
-2.1%
|
33,81
|
2.535.750 USD
|
|
|
2023-05-17 |
2023-05-12 |
V
Verkauf
|
A2A Pharmaceuticals, Inc.
Large shareholder
|
25.000
-0.7%
33,84
846.000 USD
|
25.000
-0.7%
|
33,84
|
846.000 USD
|
|
|
2023-05-10 |
2023-05-09 |
V
Verkauf
|
A2A Pharmaceuticals, Inc.
Large shareholder
|
150.000
-3.9%
34,50
5.175.720 USD
|
150.000
-3.9%
|
34,50
|
5.175.720 USD
|
|
|
2023-05-10 |
2023-05-08 |
V
Verkauf
|
A2A Pharmaceuticals, Inc.
Large shareholder
|
100.000
-2.6%
33,99
3.399.310 USD
|
100.000
-2.6%
|
33,99
|
3.399.310 USD
|
|
|
2023-04-26 |
2023-04-20 |
V
Verkauf
|
A2A Pharmaceuticals, Inc.
Large shareholder
|
200.000
-4.9%
29,12
5.823.760 USD
|
200.000
-4.9%
|
29,12
|
5.823.760 USD
|
|
|
2023-04-03 |
2023-03-30 |
K
Kauf
|
Chen Bihua
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
400.000
+12.6%
30,00
12.000.000 USD
|
400.000
+12.6%
|
30,00
|
12.000.000 USD
|
|
|
2022-11-16 |
2022-11-14 |
K
Kauf
|
Hitchcock Michael J.M.
Nicht geschäftsführender Verwaltungsratsmitglied
|
5.000
+inf%
7,93
39.650 USD
|
5.000
+inf%
|
7,93
|
39.650 USD
|
|
|
2022-11-14 |
2022-11-11 |
K
Kauf
|
Valle Franco
Chief Financial Officer
Führungsperson
|
4.100
+30.8%
7,63
31.286 USD
|
4.100
+30.8%
|
7,63
|
31.286 USD
|
|
|
2022-07-25 |
2022-07-21 |
V
Verkauf
|
A2A Pharmaceuticals, Inc.
Large shareholder
|
34.658
-0.8%
11,21
388.516 USD
|
34.658
-0.8%
|
11,21
|
388.516 USD
|
|
|
2022-06-28 |
2022-06-24 |
V
Verkauf
|
A2A Pharmaceuticals, Inc.
Large shareholder
|
34.658
-0.8%
11,76
407.578 USD
|
34.658
-0.8%
|
11,76
|
407.578 USD
|
|
|
2022-01-18 |
2022-01-14 |
K
Kauf
|
Valle Franco
Chief Financial Officer
Führungsperson
|
10.000
+inf%
8,68
86.767 USD
|
10.000
+inf%
|
8,68
|
86.767 USD
|
|
|
2021-04-22 |
2021-04-20 |
K
Kauf
|
Chen Bihua
Nicht geschäftsführender Verwaltungsratsmitglied
|
900.000
+39.6%
17,00
15.300.000 USD
|
900.000
+39.6%
|
17,00
|
15.300.000 USD
|
|
